María Maqueda

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun, Lin Shen, Manish A. Shah et al. · The Lancet · 2021 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +14

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study

Ken Kato, J-M. Sun, Manan Shah et al. · Annals of Oncology · 2020 · 131 citations

Medicine, Oncology, Pharmacology +9

Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts

Miguel Vizoso, Marta Puig, F. Javier Carmona et al. · Carcinogenesis · 2015 · 110 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence

Marta Gabasa, Evette S. Radisky, Rafael Ikemori et al. · Cancer Letters · 2021 · 60 citations · Full text

Medicine, Cell Biology, Oncology +15